TY - JOUR
T1 - Testicular dysgenesis syndrome and phthalate exposure
T2 - A review of literature
AU - Erkekoglu, Pınar
AU - Özyurt, Aylin Balcı
AU - Yirün, Anıl
AU - Çakır, Deniz Arca
N1 - Publisher Copyright:
© 2021, Pharmaceutical Association of Serbia. All rights reserved.
PY - 2021
Y1 - 2021
N2 - Endocrine disruptors are chemicals that interfere with the body’s endocrine system and cause adverse effects in biological systems. Phthalates are a group of man-made chemicals which are mainly used as plasticizers and classified as endocrine disruptors. They are also used in cosmetic and personal care products as color or smell fixators. Moreover, phthalates are present in inks, adhesives, sealants, automobile parts, tools, toys, carpets, medical tubing and blood storage bags, and food packages. Pathological condition known as “testicular dysgenesis syndrome” (TDS) or “phthalate syndrome” is usually linked to phthalate exposure and is coined to describe the rise in alterations in reproductive health in men, such as reduced semen quality (decrease in sperm counts, sperm motility and increase in abnormal sperms), hypospadias, cryptorchidism, reduced anogenital distance and early-life testicular cancer. Phthalates are suggested to cause direct effect on gonadal and non-gonadal tissues, impair the differentiation and morphogenesis of seminiferous tubules and accessory sex organs and testicular cells (both Sertoli and Leydig cells), alter estradiol and/or testosterone levels, decrease insulin-like 3 (INSL3) peptide production, impair spermatogenesis and lead to epigenetic alterations, all of which may lead to TDS. This review will mainly focus on phthalates as causes of TDS and their mechanisms of action.
AB - Endocrine disruptors are chemicals that interfere with the body’s endocrine system and cause adverse effects in biological systems. Phthalates are a group of man-made chemicals which are mainly used as plasticizers and classified as endocrine disruptors. They are also used in cosmetic and personal care products as color or smell fixators. Moreover, phthalates are present in inks, adhesives, sealants, automobile parts, tools, toys, carpets, medical tubing and blood storage bags, and food packages. Pathological condition known as “testicular dysgenesis syndrome” (TDS) or “phthalate syndrome” is usually linked to phthalate exposure and is coined to describe the rise in alterations in reproductive health in men, such as reduced semen quality (decrease in sperm counts, sperm motility and increase in abnormal sperms), hypospadias, cryptorchidism, reduced anogenital distance and early-life testicular cancer. Phthalates are suggested to cause direct effect on gonadal and non-gonadal tissues, impair the differentiation and morphogenesis of seminiferous tubules and accessory sex organs and testicular cells (both Sertoli and Leydig cells), alter estradiol and/or testosterone levels, decrease insulin-like 3 (INSL3) peptide production, impair spermatogenesis and lead to epigenetic alterations, all of which may lead to TDS. This review will mainly focus on phthalates as causes of TDS and their mechanisms of action.
KW - Endocrine disruptor chemicals
KW - Male reproductive system defects
KW - Phthalate
KW - Testicular dysgenesis syndrome
UR - http://www.scopus.com/inward/record.url?scp=85126030038&partnerID=8YFLogxK
U2 - 10.5937/ARHFARM71-34438
DO - 10.5937/ARHFARM71-34438
M3 - Review article
AN - SCOPUS:85126030038
SN - 0004-1963
VL - 71
SP - 508
EP - 543
JO - Arhiv za Farmaciju
JF - Arhiv za Farmaciju
IS - 6
ER -